A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
FISH, ALL, TCF3/PBX1, t(1:19)(q23.3:p13.3)
Test Code90511
Preferred Specimen
3 mL bone marrow or 5 mL whole blood collected in a sodium heparin (green-top) tube
Minimum Volume
1 mL bone marrow • 3 mL whole blood
Other Acceptable Specimens
Bone marrow collected in: Transport medium, sodium heparin (royal blue-top) tube, sodium heparin lead free (tan-top) tube • Whole blood collected in: Sodium heparin (royal blue-top) tube, sodium heparin lead free (tan-top) tube • 5x5mm fresh tumor tissue in transport medium
Transport Temperature
Room temperature
Specimen Stability
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Methodology
Fluorescence in situ Hybridization (FISH)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 5-7 days
Clinical Significance
FISH testing with the TCF3-PBX1 dual fusion dual color probe allows detection of balanced and unbalanced translocations involving 1q23.3 (PBX1) and 19p13.3 (TCF3). This translocation has been observed in acute lymphoblastic leukemia with a precursor-B immunophenotype. Furthermore, a variant translocation, involving 17q22 (HLF) and 19p13.3 (TCF3) can be detected with this probe.